Related Experiment Video
Updated: Sep 24, 2025

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
ZAP70 Activation Compensates for Loss of Class IA PI3K Isoforms Through Activation of the JAK-STAT3 Pathway
Melike Demir1, Onur Cizmecioglu1
1Department of Molecular Biology and Genetics, Bilkent University, Ankara, Turkey.
Background/Aim:
Tyrosine kinases have crucial functions in cell signaling and proliferation. The phosphatidylinositol 3-kinase (PI3K) pathway is frequently deregulated in human cancer and is an essential regulator of cellular proliferation. We aimed to determine which tyrosine kinases contribute to resistance elicited by PI3K silencing and inhibition.
Materials And Methods:
To mimic catalytic inactivation of p110α/β, specific p110α (BYL719) and p110β (KIN193) inhibitors were used in addition to genetic knock-out in in vitro assays. Cell viability was assessed using crystal violet staining, whereas cellular transformation ability was analyzed by soft-agar growth assays.
Results:
Activated zeta chain of T-cell receptor-associated protein kinase 70 (ZAP70) generated resistance to PI3K inhibition. This resistance was via activation of the Janus kinase/signal transducer and activator of transcription 3 (JAK/STAT3) axis. We demonstrated that activated ZAP70 has a high transforming capability associated with the formation of malignant phenotype in untransformed cells and has the potential to be a tumor-initiating factor in cancer cells.
Conclusion:
ZAP70 may be a potent driver of proliferation and transformation in untransformed cells and is implicated in resistance to PI3K inhibitors in cancer cells.
Insights
Activated zeta chain of T-cell receptor-associated protein kinase 70 (ZAP70) drives cancer cell proliferation and resistance to phosphatidylinositol 3-kinase (PI3K) inhibitors by activating the JAK/STAT3 pathway.
Area of Science:
- Cellular signaling and cancer biology
- Molecular mechanisms of cancer resistance
Background:
- The phosphatidylinositol 3-kinase (PI3K) pathway is crucial for cell proliferation and frequently deregulated in cancer.
- Understanding resistance mechanisms to PI3K inhibition is vital for effective cancer therapy.
Purpose of the Study:
- To identify tyrosine kinases contributing to resistance against PI3K silencing and inhibition.
- To elucidate the role of ZAP70 in PI3K inhibitor resistance and cellular transformation.
Main Methods:
- Utilized specific inhibitors (BYL719, KIN193) and genetic knock-out to mimic p110α/β inactivation.
- Assessed cell viability using crystal violet staining and cellular transformation via soft-agar growth assays.
Main Results:
- Activated zeta chain of T-cell receptor-associated protein kinase 70 (ZAP70) conferred resistance to PI3K inhibition.
- ZAP70 activated the Janus kinase/signal transducer and activator of transcription 3 (JAK/STAT3) axis, mediating resistance.
- Activated ZAP70 demonstrated significant transforming capability, promoting malignant phenotypes and acting as a potential tumor-initiating factor.
Conclusions:
- ZAP70 is implicated as a driver of proliferation and transformation in untransformed cells.
- ZAP70 plays a key role in mediating cancer cell resistance to PI3K inhibitors.
More Related Videos
Related Concept Videos
The JAK-STAT Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
cAMP-dependent Protein Kinase Pathways
MAPK Signaling Cascades
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

